51³Ô¹ÏÍø

Inside CSL Behring's Privigen Immunoglobulin Production Facility

The chromatography column used during the production process for Privigen liquid intravenous immunoglobulin stands in the formulation room at the Privigen plant of CSL Behring, a unit of CSL Ltd., in Melbourne, Australia, on Wednesday, July 2, 2014. CSL is the world's second-biggest maker of blood-derived therapies. Photographer: Carla Gottgens/Bloomberg via Getty Images
The chromatography column used during the production process for Privigen liquid intravenous immunoglobulin stands in the formulation room at the Privigen plant of CSL Behring, a unit of CSL Ltd., in Melbourne, Australia, on Wednesday, July 2, 2014. CSL is the world's second-biggest maker of blood-derived therapies. Photographer: Carla Gottgens/Bloomberg via Getty Images
Inside CSL Behring's Privigen Immunoglobulin Production Facility
PURCHASE A LICENSE
How can I use this image?
€300.00
EUR
Getty ImagesInside CSL Behring's Privigen Immunoglobulin Production Facility, News PhotoInside CSL Behring's Privigen Immunoglobulin Production Facility, News PhotoInside CSL Behring's Privigen Immunoglobulin Production Facility Get premium, high resolution news photos at Getty ImagesProduct #:451794964
€475€115
Getty Images
In stock

DETAILS

Restrictions:
Contact your local office for all commercial or promotional uses.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Credit:
Bloomberg / Contributor
Editorial #:
451794964
Collection:
Bloomberg
Date created:
July 02, 2014
Upload date:
License type:
Rights-managed
Release info:
Not released.ÌýMore information
Source:
Bloomberg
Object name:
AUSTRALIA CSL BEHRING